SUVmax had a weak predictive ability for EGFR mutation status in lung adenocarcinoma (training set AUC = 0.582, 95% CI 0.526–0.638, testing set AUC = 0.584, 95% C0I 0.475–0.694). This evidence concerns the gene EGFR and lung adenocarcinoma.